发明名称 Respiratory syncytial virus with a genomic deficiency complemented in trans
摘要 The invention relates to pneumoviral virions comprising a viral genome that has a mutation in a gene coding for a protein that is essential for infectivity of the pneumovirus, whereby the mutation causes a virus produced from only the viral genome to lack infectivity, and whereby the virion comprises the protein in a form and in an amount that is required for infectivity of the virion. The invention also relates to methods for producing the pneumoviral virions and for using the virions in the treatment or prevention of pneumoviral infection and disease. A preferred pneumoviral virion is a virion of Respiratory Syncytial Virus in which preferably the gene for the G attachment protein is inactivated and complemented in trans.
申请公布号 US9107939(B2) 申请公布日期 2015.08.18
申请号 US200410583800 申请日期 2004.12.24
申请人 De Staat der Nederlanden, Vert. Door de Minister Van VWS 发明人 Luytjes Willem;Widjojoatmodjo Myra Noorely
分类号 A61K39/155;A61K35/76;C07K14/005;C12N7/00;A61K39/00 主分类号 A61K39/155
代理机构 Foley & Lardner LLP 代理人 Villacorta Gilberto M.;Talapatra Sunit;Foley & Lardner LLP
主权项 1. A method to induce an immune response to prevent or treat lung pathology by human Respiratory Syncytial Virus comprising administering an effective amount of a composition comprising a virion of a human Respiratory Syncytial Virus comprising a viral genome having a deletion or inactivation of only the gene coding for G attachment protein.
地址 The Hague NL